 Immunophenotyping
"Immunophenotyping" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry.
| Descriptor ID |
D016130
|
| MeSH Number(s) |
E01.370.225.812.447 E05.200.812.447 E05.478.594.450
|
| Concept/Terms |
Immunophenotyping- Immunophenotyping
- Immunophenotypings
- Subtypings, Immunologic
- Subtyping, Immunologic
- Immunologic Subtyping
- Immunologic Subtypings
Lymphocyte Subtyping- Lymphocyte Subtyping
- Lymphocyte Subtypings
- Subtyping, Lymphocyte
- Subtypings, Lymphocyte
Lymphocyte Immunophenotyping- Lymphocyte Immunophenotyping
- Immunophenotyping, Lymphocyte
- Immunophenotypings, Lymphocyte
- Lymphocyte Immunophenotypings
- Lymphocyte Phenotyping
- Lymphocyte Phenotypings
- Phenotyping, Lymphocyte
- Phenotypings, Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Immunophenotyping".
Below are MeSH descriptors whose meaning is more specific than "Immunophenotyping".
This graph shows the total number of publications written about "Immunophenotyping" by people in this website by year, and whether "Immunophenotyping" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 5 | 5 | | 1994 | 0 | 2 | 2 | | 1995 | 0 | 2 | 2 | | 1996 | 0 | 2 | 2 | | 1997 | 0 | 5 | 5 | | 1998 | 0 | 3 | 3 | | 1999 | 0 | 3 | 3 | | 2000 | 0 | 8 | 8 | | 2001 | 0 | 8 | 8 | | 2002 | 0 | 7 | 7 | | 2003 | 0 | 8 | 8 | | 2004 | 0 | 7 | 7 | | 2005 | 0 | 7 | 7 | | 2006 | 0 | 3 | 3 | | 2007 | 0 | 5 | 5 | | 2008 | 0 | 3 | 3 | | 2009 | 0 | 9 | 9 | | 2010 | 0 | 2 | 2 | | 2011 | 0 | 5 | 5 | | 2012 | 0 | 5 | 5 | | 2013 | 1 | 7 | 8 | | 2014 | 1 | 9 | 10 | | 2015 | 0 | 7 | 7 | | 2016 | 0 | 8 | 8 | | 2017 | 1 | 8 | 9 | | 2018 | 1 | 11 | 12 | | 2019 | 0 | 10 | 10 | | 2020 | 1 | 9 | 10 | | 2021 | 1 | 4 | 5 | | 2022 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunophenotyping" by people in Profiles.
-
Wang LA, Abbott JK. "Common variable immunodeficiency: Challenges for diagnosis". J Immunol Methods. 2022 10; 509:113342.
-
Siegele BJ, Stemmer-Rachamimov AO, Lilljebjorn H, Fioretos T, Winters AC, Dal Cin P, Treece A, Gaskell A, Nardi V. N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL). Genes Chromosomes Cancer. 2022 08; 61(8):449-458.
-
Dutt TS, LaVergne SM, Webb TL, Baxter BA, Stromberg S, McFann K, Berry K, Tipton M, Alnachoukati O, Zier L, Ebel G, Dunn J, Henao-Tamayo M, Ryan EP. Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease. J Immunol. 2022 02 01; 208(3):685-696.
-
Gru AA, Bhagat G, Subtil A, Raghavan SS, Pulitzer M, Chung C, Sangueza M, Plaza JA. Spindle-cell (Sarcomatoid) Variant of Cutaneous Anaplastic Large-cell Lymphoma (C-ALCL): An Unusual Mimicker of Cutaneous Malignant Mesenchymal Tumors-A Series of 11 Cases. Am J Surg Pathol. 2021 Jun 01; 45(6):796-802.
-
van Deuren RC, Arts P, Cavalli G, Jaeger M, Steehouwer M, van de Vorst M, Gilissen C, Joosten LAB, Dinarello CA, Mhlanga MM, Kumar V, Netea MG, van de Veerdonk FL, Hoischen A. Impact of rare and common genetic variation in the interleukin-1 pathway on human cytokine responses. Genome Med. 2021 05 25; 13(1):94.
-
Wang Y, Gloss B, Tang B, Dervish S, Santner-Nanan B, Whitehead C, Masters K, Skarratt K, Teoh S, Schibeci S, Fewings N, Brignone C, Triebel F, Booth D, McLean A, Nalos M. Immunophenotyping of Peripheral Blood Mononuclear Cells in Septic Shock Patients With High-Dimensional Flow Cytometry Analysis Reveals Two Subgroups With Differential Responses to Immunostimulant Drugs. Front Immunol. 2021; 12:634127.
-
Nakazawa M, Suzuki K, Takeshita M, Inamo J, Kamata H, Ishii M, Oyamada Y, Oshima H, Takeuchi T. Distinct Expression of Coinhibitory Molecules on Alveolar T Cells in Patients With Rheumatoid Arthritis-Associated and Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2021 04; 73(4):576-586.
-
Shin JJ, Catanzaro J, Yonkof JR, Delmonte O, Sacco K, Shin MS, Reddy S, Whittington PJ, Soffer G, Mustillo PJ, Sullivan KE, Notarangelo LD, Abraham RS, Romberg N, Kang I. Infectious Complications Predict Premature CD8+ T-cell Senescence in CD40 Ligand-Deficient Patients. J Clin Immunol. 2021 05; 41(4):795-806.
-
Norris GA, Tsai AC, Schneider KW, Wu YH, Caulfield T, Green AL. A novel, germline, deactivating CBL variant p.L493F alters domain orientation and is associated with multiple childhood cancers. Cancer Genet. 2021 06; 254-255:18-24.
-
Okamato Y, Ghosh T, Okamoto T, Schuyler RP, Seifert J, Charry LL, Visser A, Feser M, Fleischer C, Pedrick C, August J, Moss L, Bemis EA, Norris JM, Kuhn KA, Demoruelle MK, Deane KD, Ghosh D, Holers VM, Hsieh EWY. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14hi monocytes. J Autoimmun. 2021 02; 117:102581.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|